We report herein immunohistochemical evidence that RTX treatment in patients with SSc associates with a significant downregulation of PDGFRα and PDGFRβ expression on spindle-like cells in the skin and with attenuation of the PDGFRβ phosphorylation (activation) status. This evidence concerns the gene PDGFRA and systemic sclerosis.